These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36907105)

  • 41. Metformin and simvastatin synergistically suppress endothelin 1-induced hypoxia and angiogenesis in multiple cancer types.
    Liu J; Wang H; Zhang M; Li Y; Wang R; Chen H; Wang B; Gao X; Song S; Wang Y; Ren Y; Li J; Liu P
    Cancer Sci; 2023 Feb; 114(2):640-653. PubMed ID: 36156330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.
    Babcook MA; Shukla S; Fu P; Vazquez EJ; Puchowicz MA; Molter JP; Oak CZ; MacLennan GT; Flask CA; Lindner DJ; Parker Y; Daneshgari F; Gupta S
    Mol Cancer Ther; 2014 Oct; 13(10):2288-302. PubMed ID: 25122066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
    Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
    Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment.
    Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3493-501. PubMed ID: 21865358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance.
    Lee KJ; Moon JY; Choi HK; Kim HO; Hur GY; Jung KH; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Yoo SH; Kang KH; Lee SY
    Clin Exp Immunol; 2010 Aug; 161(2):298-305. PubMed ID: 20491794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells.
    Dastghaib S; Shojaei S; Mostafavi-Pour Z; Sharma P; Patterson JB; Samali A; Mokarram P; Ghavami S
    Cells; 2020 Oct; 9(11):. PubMed ID: 33105603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
    Nan X; Wang J; Cheng H; Yin Z; Sheng J; Qiu B; Lau CC; Yustein JT; Zhao H; Wong STC
    Cancer Lett; 2020 Jan; 469():195-206. PubMed ID: 31672491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tanshinone I and simvastatin inhibit melanoma tumour cell growth by regulating poly (ADP ribose) polymerase 1 expression.
    Zhang Y; Huang J; Huang Y; Zhang S; Wu W; Long H; Duan X; Lai Y; Wu W
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line.
    Lee SJ; Hwang JW; Yim H; Yim HJ; Woo SU; Suh SJ; Hyun JJ; Jung SW; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1299-307. PubMed ID: 24372723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
    Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
    Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma.
    Ishida CT; Zhang Y; Bianchetti E; Shu C; Nguyen TTT; Kleiner G; Sanchez-Quintero MJ; Quinzii CM; Westhoff MA; Karpel-Massler G; Prabhu VV; Allen JE; Siegelin MD
    Clin Cancer Res; 2018 Nov; 24(21):5392-5406. PubMed ID: 30037819
    [No Abstract]   [Full Text] [Related]  

  • 52. Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin.
    Hwang KE; Na KS; Park DS; Choi KH; Kim BR; Shim H; Jeong ET; Kim HR
    Invest New Drugs; 2011 Oct; 29(5):945-52. PubMed ID: 20464445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current.
    Gritti M; Würth R; Angelini M; Barbieri F; Peretti M; Pizzi E; Pattarozzi A; Carra E; Sirito R; Daga A; Curmi PM; Mazzanti M; Florio T
    Oncotarget; 2014 Nov; 5(22):11252-68. PubMed ID: 25361004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
    Al-Haidari AA; Syk I; Thorlacius H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-inflammatory effects of simvastatin in nonsteroidal anti-inflammatory drugs-induced small bowel injury.
    Kim EK; Cho JH; Jeong AR; Kim EJ; Park DK; Kwon KA; Chung JW; Kim KO; Kim JH; Kim JH; Kim YJ
    J Physiol Pharmacol; 2017 Feb; 68(1):69-77. PubMed ID: 28456771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.
    Loftus JC; Dhruv H; Tuncali S; Kloss J; Yang Z; Schumacher CA; Cao B; Williams BO; Eschbacher JM; Ross JT; Tran NL
    Mol Cancer Res; 2013 Aug; 11(8):865-74. PubMed ID: 23699535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
    Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V
    Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of senescence in primary glioblastoma cells by serum and TGFβ.
    Kumar R; Gont A; Perkins TJ; Hanson JEL; Lorimer IAJ
    Sci Rep; 2017 May; 7(1):2156. PubMed ID: 28526854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway.
    Fang Z; Tang Y; Fang J; Zhou Z; Xing Z; Guo Z; Guo X; Wang W; Jiao W; Xu Z; Liu Z
    PLoS One; 2013; 8(5):e62823. PubMed ID: 23690956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.